Company · CIK 0001855485 · SIC 2836 — Biological Products, (No Diagnostic Substances) · NYSE
Calidi Biotherapeutics, Inc. · CLDI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 AForm 4 → | Aug 19, 7:00 pm EDT | George PeoplesDirector | 4,000 | — | — | 4,000 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 7:00 pm EDT | Scott LeftwichDirector | 4,000 | — | — | 4,000 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 7:00 pm EDT | Alan R. StewartDirector | 4,000 | — | — | 4,000 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 7:00 pm EDT | Andrew C. JacksonChief Financial Officer | 14,000 | — | — | 14,000 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 7:00 pm EDT | James A SchoeneckDirector | 5,000 | — | — | 5,000 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 7:00 pm EDT | Eric E PomaChief Executive Officer | 32,000 | — | — | 32,000 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 7:00 pm EDT | Santidrian Antonio FernandezChief Scientific Officer | 16,000 | — | — | 16,000 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 7:00 pm EDT | Corazon (Corsee) D. SandersDirector | 6,000 | — | — | 6,000 | — |